Niki BioSolutions, Inc. (NIKI) Receivables (2018 - 2025)

Niki BioSolutions' (NIKI) quarterly Receivables came in at $131091.0 in Q4 2025, up 30.29% on a QoQ basis from $100613.0 in Q3 2025.

Niki BioSolutions, Inc. (NIKI) Receivables (2018 - 2025) Analysis & Trends

Niki BioSolutions (NIKI) has 8 years of Receivables data on file, last reported at $131091.0 in Q4 2025.

Quarterly Receivables changed N/A year-over-year to $131091.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $131091.0 (changed N/A YoY) and the FY2024 annual result came in at $89281.0, changed N/A from the prior year.
Receivables rose to $131091.0 in Q4 2025, from $100613.0 in the prior quarter.
In the past five years, Receivables ranged from a high of $2.6 million in Q4 2021 to a low of -$97.7 billion in Q2 2022.
A 5-year average of -$11.1 billion and a median of $110759.0 in 2023 frame the typical range for Receivables.
Annual changes were most pronounced in 2021 — Receivables surged 358.67% — and 2022, when it sank 4980.88%.
Tracing NIKI's Receivables over 5 years: stood at $2.6 million in 2021, then sank by 95.03% to $128077.0 in 2022, then retreated by 13.52% to $110759.0 in 2023, then declined by 19.39% to $89281.0 in 2024, then soared by 46.83% to $131091.0 in 2025.
The last three Receivables figures came in at $131091.0 (Q4 2025), $100613.0 (Q3 2025), and $89281.0 (Q2 2024), per Business Quant data.

Download Data